These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 11577556

  • 1. Synthetic and genetically engineered allergen derivatives for specific immunotherapy of type I allergy.
    Valenta R, Vrtala S, Focke-Tejkl M, Twardosz A, Swoboda I, Bugajska-Schretter A, Spitzauer S, Kraft D.
    Clin Allergy Immunol; 2002; 16():495-517. PubMed ID: 11577556
    [No Abstract] [Full Text] [Related]

  • 2. Allergen-specific immunotherapy.
    Niederberger V.
    Immunol Lett; 2009 Feb 21; 122(2):131-3. PubMed ID: 19100771
    [Abstract] [Full Text] [Related]

  • 3. Engineering allergens.
    Mutschlechner S, Ferreira F.
    Eur Ann Allergy Clin Immunol; 2006 Sep 21; 38(7):226-9. PubMed ID: 17124778
    [No Abstract] [Full Text] [Related]

  • 4. The future of antigen-specific immunotherapy of allergy.
    Valenta R.
    Nat Rev Immunol; 2002 Jun 21; 2(6):446-53. PubMed ID: 12093011
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Strategies for converting allergens into hypoallergenic vaccine candidates.
    Vrtala S, Focke-Tejkl M, Swoboda I, Kraft D, Valenta R.
    Methods; 2004 Mar 21; 32(3):313-20. PubMed ID: 14962766
    [Abstract] [Full Text] [Related]

  • 9. Safety of engineered allergen-specific immunotherapy vaccines.
    Focke-Tejkl M, Valenta R.
    Curr Opin Allergy Clin Immunol; 2012 Oct 21; 12(5):555-63. PubMed ID: 22885888
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening.
    Thalhamer T, Dobias H, Stepanoska T, Pröll M, Stutz H, Dissertori O, Lackner P, Ferreira F, Wallner M, Thalhamer J, Hartl A.
    J Allergy Clin Immunol; 2010 Apr 21; 125(4):926-934.e10. PubMed ID: 20371399
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R.
    Immunol Allergy Clin North Am; 2006 May 21; 26(2):179-89, v. PubMed ID: 16701139
    [Abstract] [Full Text] [Related]

  • 17. Molecular approaches for new vaccines against allergy.
    Niederberger V, Valenta R.
    Expert Rev Vaccines; 2006 Feb 21; 5(1):103-10. PubMed ID: 16451112
    [Abstract] [Full Text] [Related]

  • 18. Sublingual vaccines based on wild-type recombinant allergens.
    Van Overtvelt L, Razafindratsita A, St-Lu N, Didierlaurent A, Batard T, Lombardi V, Martin E, Moingeon P.
    Eur Ann Allergy Clin Immunol; 2006 Sep 21; 38(7):247-9. PubMed ID: 17124785
    [Abstract] [Full Text] [Related]

  • 19. Cellular and humoral mechanisms of immune tolerance in immediate-type allergy induced by specific immunotherapy.
    Möbs C, Slotosch C, Löffler H, Pfutzner W, Hertl M.
    Int Arch Allergy Immunol; 2008 Sep 21; 147(3):171-8. PubMed ID: 18594146
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.